To protect chicken flocks of the rural poor, the project will train laboratory staff to produce and trial I-2 Newcastle disease vaccine, to assist Ethiopia in the sustainable production of vaccine.
This project will benefit poor women and children in Ethiopian villages. Villagers depend on small flocks of scavenging chickens for income and food. Newcastle disease (ND), caused by a virus, is often fatal in unvaccinated chickens and can destroy entire village flocks. The Ethiopian government wants to produce the vaccine. Locally produced thermotolerant I-2 vaccine will protect chickens against ND and helps poor rural women and children by providing a chicken “bank” for use in lean times.
Teach Gov’t Vet Lab to produce I-2 ND vaccine; Teach Gov’t Agricultural Extension staff and interested NGOs how to select and educate community vaccinators to vaccinate chickens; Work on building sustainable distribution mechanisms for the vaccine.
Scavenging chickens are the only disposable resource of most impoverished villagers. Our vaccine protects chickens and so has a positive impact on the lives of poor women and children.
- Professor Emeritus Peter Spradbrow, Vaccine developer, project technical adviser
This project has been retired and is no longer accepting donations.
This project has provided additional documentation in a PDF file (projdoc.pdf).
This project is no longer accepting donations.
Still want to help?
Find another project in
Ethiopia
or in
Women and Girls
that needs your help.
Brisbane,
Queensland,
Australia
http://www.vsap.uq.edu.au/RuralPoultry/
Projects on globalgiving.org undergo compliance checks to ensure they have a bona fide charitable purpose and meet applicable laws relating to international philanthropy. Organizations listed as partners do not necessarily endorse or support any particular project listed on globalgiving.org. The GlobalGiving Foundation is a 501(c)3 organization (EIN: 30-0108263).
GlobalGiving
1023 15th Street, NW, 12th Floor, Washington, DC 20005
Phone: (202) 232-5784 Fax: (202) 315-2558
Contact us


